文献速递创伤与烧伤重症综合管理与镇静镇痛

重型创伤性脑损伤患者凝血病的独特模式:失血性休克试验的主成分分析

Unique Pattern of Coagulopathy Among Patients With Severe Traumatic Brain Injury: A Principal Component Analysis of Hemorrhagic Shock Trials.
PubMed 文献 · Crit Care Med · 2026-01-08
一句话结论回顾性分析显示,重型TBI患者无论是否合并其他损伤,其凝血生物标志物模式与单纯躯干/四肢创伤不同,且与早期输血需求增加相关。

本研究为回顾性队列研究,整合六项失血性休克试验的统一数据库,纳入506例有完整INR、血栓弹力图和简明损伤评分数据的受试者,分为单纯重型TBI(51例)、重型多发伤(115例)和单纯重型躯干/四肢创伤(340例)。对INR和血栓弹力图值进行分层主成分分析,每个分层识别出两个主成分,解释超过65%的方差。在单纯重型TBI和重型多发伤中,第一主成分包含INR、α角、K时间和最大振幅,与早期输血几率增加相关(单纯重型TBI OR 3.57,95%CI 1.50-8.45,p=0.004;重型多发伤 OR 2.29,95%CI 1.11-4.75,p=0.026);而在单纯重型躯干/四肢创伤中,第一主成分包含INR、α角和最大振幅,与早期输血几率降低相关(OR 0.51,95%CI 0.37-0.70,p<0.001)。结论认为,主成分分析显示了重型TBI患者共有的独特凝血生物标志物模式,与是否合并其他损伤无关。

要点

  • 在重型TBI患者中,第一主成分(包含INR、α角、K时间、最大振幅)与早期输血几率增加相关(OR 3.57,95%CI 1.50-8.45,p=0.004)。
  • 重型多发伤患者的第一主成分同样包含INR、α角、K时间、最大振幅,与早期输血几率增加相关(OR 2.29,95%CI 1.11-4.75,p=0.026)。
  • 单纯重型躯干/四肢创伤患者的第一主成分包含INR、α角和最大振幅,与早期输血几率降低相关(OR 0.51,95%CI 0.37-0.70,p<0.001)。
  • 每个分层识别出的两个主成分均解释超过65%的方差。
  • 研究纳入506例受试者,其中单纯重型TBI 51例、重型多发伤115例、单纯重型躯干/四肢创伤340例。

适用人群与场景

  • 纳入标准:来自六项失血性休克试验(COMBAT、CriSP-HS、PAMPer、PPOWER、PROPPR、STAAMP)中随机分配至安慰剂或标准治疗组、且INR、血栓弹力图值(α角、K时间、最大振幅、30分钟溶解)和简明损伤评分数据完整的受试者。
  • 排除标准:COMBAT和CriSP-HS的受试者经筛选后因不符合纳入标准而被排除在最终分析之外。

诊断标准与关键阈值

  • 分层依据简明损伤评分定义为:单纯重型TBI(iTBI)、重型多发伤(POLY,同时有主要头部损伤和躯干/四肢创伤)、单纯重型躯干/四肢创伤(iTRUNK)。

研究设计与关键结果

  • 研究类型:回顾性队列研究,整合六项失血性休克试验的统一数据库。
  • 样本量:506例受试者,其中单纯重型TBI 51例、重型多发伤115例、单纯重型躯干/四肢创伤340例。
  • 干预与对照:无干预,所有受试者随机分配至安慰剂或标准治疗组。
  • 主要终点结果:对INR和血栓弹力图值进行分层主成分分析,每个分层识别出两个主成分,解释超过65%的方差。
  • 关键次要终点:在单纯重型TBI和重型多发伤中,第一主成分包含INR、α角、K时间和最大振幅,与早期输血几率增加相关(单纯重型TBI OR 3.57,95%CI 1.50-8.45,p=0.004;重型多发伤 OR 2.29,95%CI 1.11-4.75,p=0.026);在单纯重型躯干/四肢创伤中,第一主成分包含INR、α角和最大振幅,与早期输血几率降低相关(OR 0.51,95%CI 0.37-0.70,p<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论:主成分分析显示了重型TBI患者共有的独特凝血生物标志物模式,与是否合并其他损伤无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Trauma-induced coagulopathy biomarkers may be influenced by injury mechanism. We sought to identify differences in patterns of coagulopathy with and without severe traumatic brain injury (TBI).

DESIGN: Retrospective cohort study.

SETTING: Harmonized database composed of six major hemorrhagic shock trials: Control of Major Bleeding After Trauma (COMBAT), Cold-stored Platelet Early Intervention in Hemorrhagic Shock (CriSP-HS), Prehospital Air Medical Plasma (PAMPer), Prehospital Whole Blood in Emergency Resuscitation (PPOWER), Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR), and Study of Tranexamic Acid During Air Medical and Ground Prehospital Transport (STAAMP).

PATIENTS: All subjects randomized to placebo or standard-of-care groups with complete data for international normalized ratio (INR), thromboelastography values (alpha angle [AA], K time, maximum amplitude [MA], and lysis in 30 min), and Abbreviated Injury Scores (AISs). Subjects from COMBAT and CriSP-HS were screened and ultimately excluded from the final analysis as they did not meet eligibility criteria.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Stratified principal component (PC) analysis was performed for INR and thromboelastography values. Strata were defined based on AIS scores as: 1) isolated severe TBI (iTBI); 2) severe polytrauma (POLY), those with both major head injury and torso/extremity trauma; and 3) isolated severe torso/extremity trauma (iTRUNK). We identified 506 subjects with complete data: 51 iTBI, 115 POLY, and 340 iTRUNK. For each stratum, two PCs were identified that accounted for more than 65% of the variance. Associations between PC scores and outcomes, including need for blood product transfusion within 24 hours as a surrogate marker for early coagulopathy and bleeding, were examined with logistic regression. For both iTBI and POLY, PC1 included INR, AA, K time, and MA, and was associated with greater odds of early transfusion (odds ratio [OR], 3.57; 95% CI, 1.50-8.45; p = 0.004 for iTBI and OR, 2.29; 95% CI, 1.11-4.75; p = 0.026 for POLY). For iTRUNK, PC1 included INR, AA, and MA and was protective with reduced odds of early transfusion (OR, 0.51; 95% CI, 0.37-0.70; p < 0.001).

CONCLUSIONS: PC analysis demonstrated a unique pattern of coagulation biomarkers common to patients with severe TBI, irrespective of other injuries.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Furman LM, Bizri N, Feeney EV, et al. Unique Pattern of Coagulopathy Among Patients With Severe Traumatic Brain Injury: A Principal Component Analysis of Hemorrhagic Shock Trials. Crit Care Med. 2026. PMID: 41504542. doi:10.1097/CCM.0000000000007005

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。